...
首页> 外文期刊>Process Biochemistry >Effect of angiotensin I-converting enzyme (ACE) inhibition and nitric oxide (NO) production of 6,6′-bieckol, a marine algal polyphenol and its anti-hypertensive effect in spontaneously hypertensive rats
【24h】

Effect of angiotensin I-converting enzyme (ACE) inhibition and nitric oxide (NO) production of 6,6′-bieckol, a marine algal polyphenol and its anti-hypertensive effect in spontaneously hypertensive rats

机译:海洋藻类多酚6,6'-bieckol对血管紧张素I转化酶(ACE)的抑制作用和一氧化氮(NO)的产生及其对自发性高血压大鼠的降压作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the present study, the effects of 6,6'-bieckol isolated from Ecklonia cava on angiotensin I-converting enzyme (ACE) inhibition and nitric oxide (NO) production, and the inhibitor's binding modes using the crystal structure of ACE were examined. The effects of 6,6'-bieckol on systolic blood pressure (SBP) after meals were also investigated. We predicted the 3D structure of ACE and used a docking algorithm to understand the binding between ACE and 6,6'-bieckol. The molecular docking study revealed that ACE inhibitory activity of 6,6'-bieckol was mainly attributed to the hydrogen bond interactions (Lys454, His353, Glu162, G1u376, Glu384 and Glu411) and Pi interactions (Lys511 and His513) between ACE and 6,6'-bieckol. 6,6'-bieckol significantly increased the production of nitric oxide (NO) and by phosphorylating endothelial nitric oxide synthase (eNOS) in human endothelial cells. Furthermore, antihypertensive effect in spontaneously hypertensive rats (SHRs) also revealed that oral administration of the compound can down-regulate (28.6 mmHg in 6 h) systolic blood pressure (SBP).
机译:在本研究中,检查了从Ecklonia cava分离出的6,6'-bieckol对血管紧张素I转化酶(ACE)抑制和一氧化氮(NO)产生的影响,以及使用ACE晶体结构的抑制剂的结合模式。还研究了餐后6,6'-bieckol对收缩压(SBP)的影响。我们预测了ACE的3D结构,并使用对接算法来了解ACE与6,6'-bieckol之间的结合。分子对接研究表明,6,6'-bieckol的ACE抑制活性主要归因于ACE与6之间的氢键相互作用(Lys454,His353,Glu162,G1u376,Glu384和Glu411)和Pi相互作用(Lys511和His513)。 6'-bieckol。 6,6'-bieckol可以显着增加一氧化氮(NO)的产生,并通过磷酸化人内皮细胞中的内皮一氧化氮合酶(eNOS)。此外,对自发性高血压大鼠(SHRs)的降压作用还表明,口服该化合物可下调收缩压(SBP)(6 h内为28.6 mmHg)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号